why choose us

Clinical Trials Search

Showing 14,670 of 132,963 result(s)
A Study of Doravirine;Islatravir (DOR;ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR;ISL (MK-8591A-054)

Status: ACTIVE_NOT_RECRUITING

Condition: HIV Infection

Interventions: FDC tablet of 100 mg doravirine (DOR);0.25 mg islatravir (ISL) taken once daily

Date: 2023-03-01

Neurovisual Function in CHARGE Syndrome

Status: Completed

Condition: CHARGE Syndrome

Interventions: visual function evaluation

Date: 2023-03-01

Endorphin Massage Application to Women Who Gave Birth Vaginally

Status: Completed

Condition: Pain

Interventions:

With the anterior surface of the fingertips of the hand, a "V" will be drawn slowly, starting from the sacral region and towards the ribs

Date: 2023-03-01

Quadratus Lumborum Block for Total Abdominal Hysterectomy

Status: COMPLETED

Condition: Postoperative Pain

Interventions: QLB is ultrasound-guided injection of 30 ml bupivacaine 0.25% into quadratus lumborum plane posterior to the end of internal oblique muscle.

Date: 2023-03-01

Assessment of Body Composition and Physical Function

Status: COMPLETED

Condition: Body Composition

Interventions: Assessment of body composition using bioelectrical impedance analysis.

Date: 2023-03-01

Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens

Status: COMPLETED

Condition: Presbyopia

Interventions: Investigational silicone hydrogel multifocal contact lenses

Date: 2023-03-01

The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses

Status: COMPLETED

Condition: Refractive Errors

Interventions: Reusable silicone hydrogel contact lenses worn during the day and removed at night for cleaning and disinfection

Date: 2023-03-01

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

Status: NOT_YET_RECRUITING

Condition: Prostate Cancer

Interventions: Gonadotropin-releasing hormone (GnRH) antagonist, oral tablet taken 1x daily.

Date: 2023-03-01

Comprehensive Tobacco Cessation for Cancer Patients and Survivors

Status: Completed

Condition: Tobacco Use Cessation

Interventions:

Participants can choose to receive behavioral counseling in group v. individual format:

Group Sessions: Participants will be offered the oppo

Date: 2023-03-01

Clinician Training Program to Integrate Digital CBTI Into Routine Psychotherapy

Status: Completed

Condition: Insomnia

Interventions: in session support for adherence to and engagement with digital CBTI

Date: 2023-03-01